Pages that link to "Q36384836"

The following pages link to Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). (Q36384836):

Displaying 48 items.

• Immunomodulatory drug FTY720 induces regulatory CD4(+)CD25(+) T cells in vitro (Q24648847) ‎ (← links)
• Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier (Q27322655) ‎ (← links)
• Acute graft-versus-host disease: a bench-to-bedside update (Q27687130) ‎ (← links)
• An engineered macroencapsulation membrane releasing FTY720 to precondition pancreatic islet transplantation. (Q30253082) ‎ (← links)
• Imaging Plasmodium immunobiology in the liver, brain, and lung (Q30561036) ‎ (← links)
• Altered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease (Q33851696) ‎ (← links)
• Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy (Q33917765) ‎ (← links)
• Advances in graft-versus-host disease biology and therapy (Q34031916) ‎ (← links)
• CCR7 expressing mesenchymal stem cells potently inhibit graft-versus-host disease by spoiling the fourth supplemental Billingham's tenet (Q34790016) ‎ (← links)
• Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation (Q35586614) ‎ (← links)
• Advances in understanding the pathogenesis of graft-versus-host disease (Q35971439) ‎ (← links)
• Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation (Q36130498) ‎ (← links)
• Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation. (Q36219724) ‎ (← links)
• FTY720 markedly increases alloengraftment but does not eliminate host anti-donor T cells that cause graft rejection on its withdrawal (Q36462344) ‎ (← links)
• The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment (Q36473213) ‎ (← links)
• Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? (Q37035815) ‎ (← links)
• Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality (Q37042232) ‎ (← links)
• IL4RA on lymphatic endothelial cells promotes T cell egress during sclerodermatous graft versus host disease (Q37183184) ‎ (← links)
• Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism (Q37211290) ‎ (← links)
• T-lymphocyte interaction with stromal, bone and hematopoietic cells in the bone marrow. (Q37333685) ‎ (← links)
• Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia (Q37412327) ‎ (← links)
• Acute graft-versus-host disease: from the bench to the bedside (Q37420496) ‎ (← links)
• IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation (Q37484523) ‎ (← links)
• Immunoregulation of GVHD by triggering the innate immune system with CpG (Q37810081) ‎ (← links)
• Regulatory T cells and IL-17-producing cells in graft-versus-host disease (Q37900645) ‎ (← links)
• Immunobiology of Plasmodium in liver and brain (Q38103059) ‎ (← links)
• Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer (Q38198742) ‎ (← links)
• Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia (Q38714704) ‎ (← links)
• Novel targets in the treatment of chronic graft-versus-host disease (Q39023963) ‎ (← links)
• Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy (Q39161011) ‎ (← links)
• miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency (Q41049761) ‎ (← links)
• CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy (Q41480472) ‎ (← links)
• Sphingosine 1-Phosphate Signaling and Its Pharmacological Modulation in Allogeneic Hematopoietic Stem Cell Transplantation. (Q41995676) ‎ (← links)
• Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy (Q49679320) ‎ (← links)
• Tumor-specific allogeneic cells for cancer therapy (Q50063348) ‎ (← links)
• Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling. (Q51450182) ‎ (← links)
• MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function. (Q52714530) ‎ (← links)
• Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model. (Q53646949) ‎ (← links)
• Regulatory T cells in the treatment of disease (Q57471979) ‎ (← links)
• Activation of the Nuclear Erythroid 2-Related Factor 2 Antioxidant Responsive Element (Nrf2-ARE) Signaling Pathway Alleviates Acute Graft-Versus-Host Disease by Reducing Oxidative Stress and Inhibiting Infiltration of Inflammatory Cells in an Allogen (Q58700603) ‎ (← links)
• Attenuation of murine sclerodermatous models by the selective S1P receptor modulator cenerimod (Q61444734) ‎ (← links)
• Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease (Q81796868) ‎ (← links)
• The effect of azithromycin on the maturation and function of murine bone marrow-derived dendritic cells (Q82385519) ‎ (← links)
• Efficacy of azithromycin in preventing lethal graft-versus-host disease (Q86052152) ‎ (← links)
• Successful treatment with fingolimod of graft-versus-host disease of the central nervous system (Q89893903) ‎ (← links)
• Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality (Q90440719) ‎ (← links)
• Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis (Q91106268) ‎ (← links)
• Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease (Q91782610) ‎ (← links)